Not only did we set up COVAX, but we are one of its largest donors. We have committed ourselves to donating 100 million doses, and that is part of the G7 commitment to sharing 870 million by 2022. Furthermore, we are helping many countries to set up their own vaccine manufacturing. Last Thursday I visited the Institut Pasteur de Dakar in Senegal, which, thanks to help from the UK with the delivery of a business plan, now has the necessary investment to ensure that it will be one of the first manufacturers of covid vaccines in Africa.
A small proportion of those who are vaccinated against covid-19 suffer adverse reactions. Can my hon. Friend explain why, under the COVAX compensation scheme, we give more generous compensation—paid for by our taxpayers—to citizens in foreign countries than we give to our own citizens who suffer adverse consequences from the covid-19 vaccine?